Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Piperacillin and tazobactam adverse reaction |
Causative agent (attribute) |
False |
Piperacillin with tazobactam |
Inferred relationship |
Some |
|
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin with tazobactam |
Inferred relationship |
Some |
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin with tazobactam |
Inferred relationship |
Some |
|
Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin with tazobactam |
Inferred relationship |
Some |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin with tazobactam |
Inferred relationship |
Some |
|
Piperacillin sodium ns/tazobactam sodium ns injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin with tazobactam |
Inferred relationship |
Some |
|
Piperacillin+tazobactam 36g/4.5g injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin with tazobactam |
Inferred relationship |
Some |
|
Piperacillin with tazobactam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin with tazobactam |
Inferred relationship |
Some |
|